<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="BiosciCell &amp;amp; Bioscience2045-3701BioMed CentralLondon pmcid: 6555941308 doi: 10.1186/s13578-019-0308-9 : Research" exact="Zika" post="virus antagonizes interferon response in patients and disrupts RIG-I–MAVS"/>
 <result pre="Background The emerging threat to global health associated with the" exact="Zika" post="virus (ZIKV) epidemics and its link to severe complications"/>
 <result pre="role of type I interferon (IFN-I) in protecting hosts from" exact="ZIKV" post="infection lies in the findings that ZIKV has evolved"/>
 <result pre="protecting hosts from ZIKV infection lies in the findings that" exact="ZIKV" post="has evolved various strategies to subvert the host defense"/>
 <result pre="subsequent IFN signaling. Yet, mechanisms underlying the counter-IFN capability of" exact="ZIKV" post="and its proteins, which might contribute to the well-recognized"/>
 <result pre="inactive as compared to those of healthy donors, suggesting that" exact="ZIKV" post="was able to suppress the induction of IFN-I during"/>
 <result pre="in humans. Furthermore, by analyzing the molecular interaction in a" exact="ZIKV" post="NS4A-overexpression system, or in the context of actual ZIKV"/>
 <result pre="a ZIKV NS4A-overexpression system, or in the context of actual" exact="ZIKV" post="infection, we identified that ZIKV NS4A directly bound MAVS"/>
 <result pre="in the context of actual ZIKV infection, we identified that" exact="ZIKV" post="NS4A directly bound MAVS and thereby interrupted the RIG-I/MAVS"/>
 <result pre="attenuated production of IFN-I. Conclusions Our findings collectively revealed that" exact="ZIKV" post="NS4A targeted MAVS and contributed to ZIKV immune evasion"/>
 <result pre="collectively revealed that ZIKV NS4A targeted MAVS and contributed to" exact="ZIKV" post="immune evasion through abrogating MAVS-mediated IFN production. These findings"/>
 <result pre="new knowledge and molecular details to our understanding regarding how" exact="ZIKV" post="mediates suppression of the IFN-I system and may provide"/>
 <result pre="contains supplementary material, which is available to authorized users. Keywords" exact="Zika" post="virus Nonstructural protein 4A Interferon RIG-I MAVS Background Zika"/>
 <result pre="Keywords Zika virus Nonstructural protein 4A Interferon RIG-I MAVS Background" exact="Zika" post="virus (ZIKV) is an emerging mosquito-borne pathogen belonging to"/>
 <result pre="virus (JEV), dengue virus (DENV), yellow fever virus (YFV) and" exact="West Nile" post="virus (WNV) [1]. While ZIKV was originally identified in"/>
 <result pre="fever virus (YFV) and West Nile virus (WNV) [1]. While" exact="ZIKV" post="was originally identified in the Zika forest of Uganda"/>
 <result pre="virus (WNV) [1]. While ZIKV was originally identified in the" exact="Zika" post="forest of Uganda in 1947 and the first human"/>
 <result pre="human infection case was documented in 1954, the most serious" exact="Zika" post="pandemic to date began in the Americas in 2013–2014"/>
 <result pre="over 86 countries and territories have reported cases of active" exact="ZIKV" post="transmission [3]. Clinically, although most Zika cases are asymptomatic"/>
 <result pre="reported cases of active ZIKV transmission [3]. Clinically, although most" exact="Zika" post="cases are asymptomatic or only manifest as an influenza-like"/>
 <result pre="or only manifest as an influenza-like illness, severe forms of" exact="ZIKV" post="infection such as microcephaly and other neurological abnormalities in"/>
 <result pre="based on which severe diseases develop as a result of" exact="ZIKV" post="infection is key to developing strategies against ZIKV-associated conditions."/>
 <result pre="in the prM [5] and NS1 [6] proteins might enable" exact="ZIKV" post="to become more virulent and/or transmissible, mounting evidence suggests"/>
 <result pre="suggests that innate immunity is involved in the governance of" exact="ZIKV" post="replication and pathogenesis [1, 7]. The interferon (IFN) system,"/>
 <result pre="constitutes the first line of defense against viral infection, including" exact="ZIKV" post="[7]. A vital role for the IFN system in"/>
 <result pre="[7]. A vital role for the IFN system in abrogating" exact="ZIKV" post="infection in the host was revealed by the fact"/>
 <result pre="infection in the host was revealed by the fact that" exact="ZIKV" post="is pathogenic in IFN receptor knockout mice but not"/>
 <result pre="mice [8–10]. Moreover, Smith et al. demonstrated the neuropathogenesis of" exact="ZIKV" post="in a highly susceptible immunocompetent mouse model after the"/>
 <result pre="that in order for a pathogenic infection to be established," exact="ZIKV" post="needs to attenuate the production of IFNs or the"/>
 <result pre="two of the most important PRRs for the detection of" exact="ZIKV" post="infection [7, 15]. RIG-I recognizes cytosolic viral RNA of"/>
 <result pre="in responding to infection of positive-sense, single-stranded RNA viruses, including" exact="ZIKV" post="[17]. STING has also been found to interact with"/>
 <result pre="and the downstream signaling pathways. Currently available data suggest that" exact="ZIKV" post="infection can inhibit type I IFN responses in dendritic"/>
 <result pre="yet the interferon response in other cell types remains unknown." exact="ZIKV" post="genome codes for a single polyprotein that is post-translationally,"/>
 <result pre="(NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) [1]. The" exact="ZIKV" post="nonstructural proteins NS1, NS2B3, NS4B, and NS5 have been"/>
 <result pre="NS4B, and NS5 have been implicated to be engaged in" exact="ZIKV" post="immuno pathogenicity through diverse strategies. For example, NS1 and"/>
 <result pre="pathogenicity through diverse strategies. For example, NS1 and NS4B of" exact="ZIKV" post="inhibit RLR-induced IFN-β production via interacting with TBK1 and"/>
 <result pre="facilitating proteasomal degradation of Jak1 [19] and STING [17]. Furthermore," exact="ZIKV" post="NS5 has been found to bind and degrade host"/>
 <result pre="MAVS signaling is essential for inducing an IFN production during" exact="ZIKV" post="infection, it is plausible that viruses may hijack this"/>
 <result pre="facilitate infection of the host. Our previous findings revealed that" exact="DENV" post="NS4A protein played an important role in suppressing interferon"/>
 <result pre="of the flavivirus group, ZIKV. This current study found that" exact="ZIKV" post="interfered with the RIG-I–MAVS signaling to attenuate type I"/>
 <result pre="type I IFN production. More specifically, our results suggest that" exact="ZIKV" post="NS4A targets MAVS and interrupts the RLR–MAVS interaction, leading"/>
 <result pre="interaction, leading to reduced induction of type I IFNs. Results" exact="ZIKV" post="suppresses type I interferon production in human subjects and"/>
 <result pre="in human subjects and in host cells To assess whether" exact="ZIKV" post="infection influences the production of type I IFN in"/>
 <result pre="previous study [23]. The clinical characteristics of three individuals with" exact="ZIKV" post="infection and the background of three healthy donors are"/>
 <result pre="undetected (TREX1 and DCP1A). To further investigate the ability of" exact="ZIKV" post="to block IFN production in response to general viral"/>
 <result pre="cultured human cells, we infected HFF-1 and SV-HUC-1 cells with" exact="ZIKV" post="and then used SeV or poly(I:C) to secondarily infect"/>
 <result pre="induced drastic production of IFN-β, pre-infection of the cells with" exact="ZIKV" post="robustly lowered the level of IFN-β produced in response"/>
 <result pre="the same RNA expression level of SeV in each group." exact="ZIKV" post="infection in HFF-1 and SV-HUC-1 was validated by western"/>
 <result pre="SV-HUC-1 was validated by western blotting analysis to detect the" exact="ZIKV" post="envelope protein (E) (Fig. 1h, i). These data demonstrated"/>
 <result pre="envelope protein (E) (Fig. 1h, i). These data demonstrated that" exact="ZIKV" post="could actively suppress the type-I IFN response in host"/>
 <result pre="in host cells and patients, warranting further investigation of how" exact="ZIKV" post="suppresses IFN production in human host cells. Fig. 1"/>
 <result pre="ZIKV suppresses IFN production in human host cells. Fig. 1" exact="ZIKV" post="abrogates the activation of type I IFN signaling. a"/>
 <result pre="statistical significance of the differential gene expression. b–e Infection with" exact="ZIKV" post="reduces type I IFN production after a secondary infection."/>
 <result pre="infection. HFF-1 and SV-HUC-1 cells were infected with mock or" exact="ZIKV" post="at an MOI of 1, and 24 h later,"/>
 <result pre="and for Western blotting analysis to determine the levels of" exact="ZIKV" post="envelope protein (E) and GAPDH protein (h, i). Data"/>
 <result pre="from three repeatedexperiments. *p &amp;lt; 0.05, and **indicates p &amp;lt; 0.01 (Student’s t test)" exact="ZIKV" post="NS4A protein abrogates IFN-I signaling Our previous finding that"/>
 <result pre="through targeting RIG-I–MAVS-mediated signaling [22] prompted us to ask whether" exact="ZIKV" post="NS4A protein is also able to interfere with RLR–MAVS-dependent"/>
 <result pre="two-hybrid analysis was performed to identify possible molecular interactions between" exact="ZIKV" post="NS4A and components along the RIG-I signaling pathway. Specifically,"/>
 <result pre="and components along the RIG-I signaling pathway. Specifically, we used" exact="ZIKV" post="NS4A to transfect 293T cells, together with, respectively, one"/>
 <result pre="by Western blotting (Additional file 3: Figure S1, A–D). When" exact="DENV" post="NS4A and ZIKV prM were used as a positive"/>
 <result pre="(Additional file 3: Figure S1, A–D). When DENV NS4A and" exact="ZIKV" post="prM were used as a positive and negative control,"/>
 <result pre="MAVS and ZIKV-NS4A, DENV2-NS4A (Fig. 2b), whereas no interaction between" exact="ZIKV" post="prM, NS4A and RIG-I, TBK1 orIKKε was found (Fig."/>
 <result pre="suggesting that MAVS might represent a specific interaction partner of" exact="ZIKV" post="NS4A. Fig. 2 Molecular interaction between ZIKV NS4A protein"/>
 <result pre="interaction partner of ZIKV NS4A. Fig. 2 Molecular interaction between" exact="ZIKV" post="NS4A protein and the type I IFN induction pathway."/>
 <result pre="screening assays were performed to identify the molecular targets of" exact="ZIKV" post="proteins in RIG-I signaling. 293T cells in 24-well plates"/>
 <result pre="(BIND) vector expressing a fusion protein of GAL4-BD and individual" exact="ZIKV" post="prM, NS4A or DENV NS4A proteins, and a pFN10A"/>
 <result pre="fusion protein of GAL4-BD and individual ZIKV prM, NS4A or" exact="DENV" post="NS4A proteins, and a pFN10A (ACT) vector expressing a"/>
 <result pre="**p &amp;lt; 0.01 (Student’s t test) To verify the above finding that" exact="ZIKV" post="NS4A interacts with MAVS, we examined whether NS4A of"/>
 <result pre="ZIKV NS4A interacts with MAVS, we examined whether NS4A of" exact="Zika" post="virus co-localizes with MAVS by performing confocal microscopy in"/>
 <result pre="induction by targeting MAVS, was employed as a positive control," exact="ZIKV" post="NS4A or PB1-F2, respectively, but not ZIKV prM, was"/>
 <result pre="a positive control, ZIKV NS4A or PB1-F2, respectively, but not" exact="ZIKV" post="prM, was found to co-localize with MAVS, supporting the"/>
 <result pre="was found to co-localize with MAVS, supporting the notion that" exact="ZIKV" post="NS4A interacts with MAVS in host cells. Fig. 3"/>
 <result pre="ZIKV NS4A interacts with MAVS in host cells. Fig. 3" exact="ZIKV" post="NS4A co-localizes and interacts with MAVS. a HeLa cells"/>
 <result pre="a HeLa cells transfected with plasmids expressing Flag-tagged NS4A, Flag-tagged" exact="ZIKV" post="prM or influenza Flag-tagged PB1-F2 were stained with anti-Flag"/>
 <result pre="NS4A were used in a co-IP assay to address whether" exact="ZIKV" post="NS4A protein physically interacts with MAVS. Cell lysates were"/>
 <result pre="antibody by Western blotting. e HFF-1 cells were infected with" exact="ZIKV" post="at an MOI of 5 followed by immunoprecipitation using"/>
 <result pre="(co-IP) assay was performed to reveal a physical interaction between" exact="ZIKV" post="NS4A and MAVS. 293T cells were co-transfected with Myc-tagged"/>
 <result pre="and MAVS, we also performed an endogenous IP assay upon" exact="ZIKV" post="infection. When HFF-1 cells were infected with ZIKV and"/>
 <result pre="assay upon ZIKV infection. When HFF-1 cells were infected with" exact="ZIKV" post="and the cell lysates were subsequently precipitated using an"/>
 <result pre="results revealed that an antibody against MAVS could pull down" exact="ZIKV" post="NS4A (Fig. 3e), suggesting that NS4A and MAVS were"/>
 <result pre="MAVS was demonstrated, strongly suggesting that NS4A directly bound MAVS." exact="ZIKV" post="NS4A interacts with both the CL and TM domains"/>
 <result pre="domains in the interaction between NS4A and MAVS. Fig. 4" exact="ZIKV" post="NS4A interacts with both the CL and TM domains"/>
 <result pre="RIG-I, modulated the downstream signaling, and consequently suppressed IFN production." exact="ZIKV" post="NS4A-MAVS interaction inhibits IFN induction and viral infection As"/>
 <result pre="induction and viral infection As the aforementioned data showed that" exact="ZIKV" post="NS4A interacts with MAVS, we next sought to determine"/>
 <result pre="production, together with increasing amounts of the expression vector containing" exact="ZIKV" post="NS4A plus the IFN-β luciferase reporter cassette. Our results"/>
 <result pre="the IFN-β luciferase reporter cassette. Our results demonstrated that when" exact="ZIKV" post="prM was used as a negative control and the"/>
 <result pre="negative control and the PB1-F2 protein of influenza virus and" exact="DENV" post="NS4A were used as a positive control, overexpression of"/>
 <result pre="DENV NS4A were used as a positive control, overexpression of" exact="ZIKV" post="NS4A indeed inhibited the reporter luciferase activity driven by"/>
 <result pre="and Additional file 3: Figure S4 A–C). Furthermore, PB1-F2 or" exact="DENV" post="NS4A, but not prM, significantly decreased the IFN-β reporter"/>
 <result pre="of interfering with the promoter activity of IFN-β. Fig. 5" exact="ZIKV" post="NS4A negatively regulates IFN production. a Lysates of 293T"/>
 <result pre="of 293T cells co-transfected with RIG-I(N), IFN-β reporter, together with" exact="ZIKV" post="NS4A (250, or 500 ng), DENV NS4A (250, or"/>
 <result pre="IFN-β reporter, together with ZIKV NS4A (250, or 500 ng)," exact="DENV" post="NS4A (250, or 500 ng), ZIKV prM (500 ng)"/>
 <result pre="(250, or 500 ng), DENV NS4A (250, or 500 ng)," exact="ZIKV" post="prM (500 ng) or PB1-F2 (500 ng)were analyzed for"/>
 <result pre="activity. 293T cells were transfected with IFN-β reporter, together with" exact="ZIKV" post="NS4A (250, or 500 ng), DENV NS4A (250, or"/>
 <result pre="IFN-β reporter, together with ZIKV NS4A (250, or 500 ng)," exact="DENV" post="NS4A (250, or 500 ng), ZIKV prM (500 ng)"/>
 <result pre="(250, or 500 ng), DENV NS4A (250, or 500 ng)," exact="ZIKV" post="prM (500 ng) or PB1-F2 (500 ng), b then"/>
 <result pre="were transfected with blank control vector or a vector expressing" exact="ZIKV" post="NS4A (500 ng), DENV NS4A (500 ng), ZIKV prM"/>
 <result pre="control vector or a vector expressing ZIKV NS4A (500 ng)," exact="DENV" post="NS4A (500 ng), ZIKV prM (500 ng) or PB1-F2"/>
 <result pre="vector expressing ZIKV NS4A (500 ng), DENV NS4A (500 ng)," exact="ZIKV" post="prM (500 ng) or PB1-F2 (500 ng), respectively, and"/>
 <result pre="and **p &amp;lt; 0.01 (Student’s t-test) To further examine the effect of" exact="ZIKV" post="NS4A on IFN-β production induced by viral infection, we"/>
 <result pre="poly(I:C) as an IFN stimulus and found that expression of" exact="ZIKV" post="NS4A, DENV NS4A or influenza PB1-F2, but not ZIKV"/>
 <result pre="an IFN stimulus and found that expression of ZIKV NS4A," exact="DENV" post="NS4A or influenza PB1-F2, but not ZIKV prM, markedly"/>
 <result pre="of ZIKV NS4A, DENV NS4A or influenza PB1-F2, but not" exact="ZIKV" post="prM, markedly inhibited the activities of IFN-β reporters upon"/>
 <result pre="in infected cells, and we found that ectopic expression of" exact="ZIKV" post="NS4A reduced IFN-β production stimulated by SeV (Fig. 5d)or"/>
 <result pre="by poly(I:C) (Fig. 5f). Taken together, these data indicated that" exact="ZIKV" post="can efficiently blocked the type-I IFN response, and that"/>
 <result pre="and ISGs (Fig. 5g, h), suggesting a pivotal role for" exact="ZIKV" post="NS4A in suppressing type I IFN signaling via interacting"/>
 <result pre="IFN signaling via interacting with MAVS. To further validate that" exact="ZIKV" post="NS4A is an antagonist of IFN production, we employed"/>
 <result pre="virus system in our study, and our data displayed that" exact="ZIKV" post="NS4A, DENV NS4A or IVA PB1-F2 remarkably reduced the"/>
 <result pre="in our study, and our data displayed that ZIKV NS4A," exact="DENV" post="NS4A or IVA PB1-F2 remarkably reduced the IFN-β reporter"/>
 <result pre="revealed that the recombinant VSV-GFP virus in 293T cells expressing" exact="ZIKV" post="NS4A, DENV NS4A or IVA PB1-F2 exhibited a high-degree"/>
 <result pre="the recombinant VSV-GFP virus in 293T cells expressing ZIKV NS4A," exact="DENV" post="NS4A or IVA PB1-F2 exhibited a high-degree replication (Fig."/>
 <result pre="replication (Fig. 6b, c), suggesting that the inhibitory effect of" exact="ZIKV" post="NS4A on IFN production could occur in the scenario"/>
 <result pre="occur in the scenario of actual viral infection. Fig. 6" exact="ZIKV" post="NS4A blocks VSV-induced IFN production. a 293T cells transfected"/>
 <result pre="microscope (c) Discussion The recent extensive epidemic out breaks of" exact="ZIKV" post="infection and its dissemination to various regions of the"/>
 <result pre="global health [1]. The rapidly emerging health crisis associated with" exact="ZIKV" post="infection highlights a growing need to understand the mechanisms"/>
 <result pre="highlights a growing need to understand the mechanisms by which" exact="ZIKV" post="accesses human hosts. Evidence for a crucial role of"/>
 <result pre="IFN response in preventing infection lies in the fact that" exact="ZIKV" post="has evolved a variety of strategies to subvert the"/>
 <result pre="present study, we demonstrated that by utilizing its NS4A protein," exact="ZIKV" post="could suppress IFN production through disrupting the RIG-I–MAVS signaling"/>
 <result pre="pathway. This finding broadens and deepens our knowledge of how" exact="ZIKV" post="has developed diverse strategies to evade the action of"/>
 <result pre="work revealed that NS4A proteins derived from various serotypes of" exact="DENV" post="blocked type I IFN production through targeting MAVS-mediated signaling"/>
 <result pre="MAVS-mediated signaling pathways [22]. Recently, Ma et al. reported that" exact="ZIKV" post="NS4A in particular as a suppressor of the RLR"/>
 <result pre="RLR–MAVS interaction, preventing induction of type I IFNs and inhibiting" exact="ZIKV" post="replication [25]. Toward understanding the counter-IFN capability of ZIKV"/>
 <result pre="inhibiting ZIKV replication [25]. Toward understanding the counter-IFN capability of" exact="ZIKV" post="in depth, our current work is featured in several"/>
 <result pre="we here provide the first and direct evidence demonstrating that" exact="ZIKV" post="NS4A directly binds MAVS protein and there by impair"/>
 <result pre="there by impair IFN production. Secondly, we have documented that" exact="ZIKV" post="is a weak inducer of type I interferon in"/>
 <result pre="in our study, serial experiments in the context of actual" exact="ZIKV" post="infection were performed, and clearly demonstrated that NS4A inhibited"/>
 <result pre="the molecular level, while antagonism of IFN-mediated signal transduction by" exact="ZIKV" post="NS4A shares multiple similarities with that of DENV NS4A,"/>
 <result pre="transduction by ZIKV NS4A shares multiple similarities with that of" exact="DENV" post="NS4A, our findings revealed that ZIKV NS4A bound MAVS"/>
 <result pre="similarities with that of DENV NS4A, our findings revealed that" exact="ZIKV" post="NS4A bound MAVS through specifically interacting with both the"/>
 <result pre="protect barrier cells of the human placenta called trophoblasts from" exact="ZIKV" post="infection. Type III IFN utilizes different cell-surface receptors than"/>
 <result pre="regulate its production [26]. Thus, it is highly likely that" exact="ZIKV" post="can also evade type III IFN signaling through targeting"/>
 <result pre="MAVS by NS4A, which may contribute to the ability of" exact="ZIKV" post="to cross the placenta during pregnancy and consequently cause"/>
 <result pre="between two proteins. Ding et al. revealed residues critical for" exact="ZIKV" post="NS2B3-mediated cleavage to R78 and G79 in the cytoplasmic"/>
 <result pre="be equally important to further map the amino acids of" exact="ZIKV" post="NS4A involved in IFN antagonism, which should allow generation"/>
 <result pre="known what has triggered the surge of recent epidemics of" exact="ZIKV" post="and the associated severe diseases [1]. Mechanistically, aberrant suppression"/>
 <result pre="of the antiviral property of IFNs might facilitate infection of" exact="ZIKV" post="as well as viral spreading in human populations. ZIKV"/>
 <result pre="of ZIKV as well as viral spreading in human populations." exact="ZIKV" post="is largely a mosquito-borne virus and can also be"/>
 <result pre="transplantation, and potentially via urine or saliva as well. Moreover," exact="ZIKV" post="may be transmitted from pregnant women to fetuses by"/>
 <result pre="route [1]. In consistence with such a dynamic transmission pattern," exact="ZIKV" post="exhibits a broad tropism and ability to persist in"/>
 <result pre="that immunocompromised human subjects or mice have increased susceptibility to" exact="ZIKV" post="infection and are more vulnerable to developing severe disease"/>
 <result pre="Moreover, it has been well documented that nonstructural proteins of" exact="ZIKV" post="play important roles in the life cycle of ZIKV"/>
 <result pre="of ZIKV play important roles in the life cycle of" exact="ZIKV" post="and that several of them, including NS1, NS2B/3, NS4A,"/>
 <result pre="of putative entry receptors on host cells being a key" exact="ZIKV" post="infection mechanism, the ability of ZIKV to defeat the"/>
 <result pre="cells being a key ZIKV infection mechanism, the ability of" exact="ZIKV" post="to defeat the host IFN system, possibly through expressing"/>
 <result pre="cellular tropism and intracellular persistence. Hence, collaborative actions among different" exact="ZIKV" post="nonstructural proteins need to be better understood, and further"/>
 <result pre="summary, the current findings revealed an innate immunity evasion by" exact="ZIKV" post="and the possible underlying molecular mechanisms. We demonstrated that"/>
 <result pre="and the possible underlying molecular mechanisms. We demonstrated that the" exact="ZIKV" post="NS4A protein plays an important role in suppressing interferon"/>
 <result pre="the RIG-I–MAVS interaction in host cells. The identified function of" exact="ZIKV" post="NS4A as an IFN antagonist might enable it to"/>
 <result pre="play an important role in the pathogenesis and spread of" exact="ZIKV" post="in humans. This work has not only found a"/>
 <result pre="son, or patients A, B, and C) were diagnosed with" exact="ZIKV" post="infection at Enping People’s Hospital in 2016. Clinical and"/>
 <result pre="publication [23]. The control subjects were three healthy volunteers without" exact="ZIKV" post="infection. All human subjects gave written, informed consent to"/>
 <result pre="is summarized and compared in Additional file 1: Table S1." exact="Zika" post="virus strain ZG-01 (GenBank accession number KY379148.1) was isolated"/>
 <result pre="as previously described [22]. Plasmids The cDNA coding for each" exact="ZIKV" post="protein, including prM, NS4A and NS4A-Flag (with a C-terminal"/>
 <result pre="coding for RIG-I (100 ng) together with a plasmid expressing" exact="ZIKV" post="NS4A, ZIKV prM, DENV NS4A or IVA PB1-F2. Empty"/>
 <result pre="RIG-I (100 ng) together with a plasmid expressing ZIKV NS4A," exact="ZIKV" post="prM, DENV NS4A or IVA PB1-F2. Empty pcDNA3 vector"/>
 <result pre="ng) together with a plasmid expressing ZIKV NS4A, ZIKV prM," exact="DENV" post="NS4A or IVA PB1-F2. Empty pcDNA3 vector was used"/>
 <result pre="stimulus, 293T cells transfected with IFN-β reporter, pRL-TK, together with" exact="ZIKV" post="NS4A, ZIKV prM, DENV NS4A or IVA PB1-F2, were"/>
 <result pre="cells transfected with IFN-β reporter, pRL-TK, together with ZIKV NS4A," exact="ZIKV" post="prM, DENV NS4A or IVA PB1-F2, were infected with"/>
 <result pre="with IFN-β reporter, pRL-TK, together with ZIKV NS4A, ZIKV prM," exact="DENV" post="NS4A or IVA PB1-F2, were infected with or without"/>
 <result pre="of pFN11A (BIND) vector expressing GAL4-BD fused with each individual" exact="Zika" post="virus protein, and plasmid pFN10A (ACT) expressing the transcriptional"/>
 <result pre="the protocol provided by the manufacturer. For SPR analysis, recombinant" exact="Zika" post="virus NS4A protein was purified using a Ni–NTA affinity"/>
 <result pre="62.5, 125, 250, 500, 1000, and 2000 nM) of purified" exact="ZIKV" post="NS4A or prM protein, or 100 microliters of blank"/>
 <result pre="1: Table S1. The clinical characteristics of three individuals with" exact="ZIKV" post="infection and the backgrounds of three healthy donors. LINK"/>
 <result pre="vivo. LINK Additional file 3. Additional figures and table. Abbreviations" exact="ZIKV" post="Zika virus IFN interferon JEV Japanese encephalitis virus DENV"/>
 <result pre="LINK Additional file 3. Additional figures and table. Abbreviations ZIKV" exact="Zika" post="virus IFN interferon JEV Japanese encephalitis virus DENV dengue"/>
 <result pre="Abbreviations ZIKV Zika virus IFN interferon JEV Japanese encephalitis virus" exact="DENV" post="dengue virus YFV yellow fever virus WNV West Nile"/>
 <result pre="virus IFN interferon JEV Japanese encephalitis virus DENV dengue virus" exact="YFV" post="yellow fever virus WNV West Nile virus IVA influenza"/>
 <result pre="Japanese encephalitis virus DENV dengue virus YFV yellow fever virus" exact="WNV" post="West Nile virus IVA influenza PAMPs pathogen-associated molecular patterns"/>
 <result pre="encephalitis virus DENV dengue virus YFV yellow fever virus WNV" exact="West Nile" post="virus IVA influenza PAMPs pathogen-associated molecular patterns PRRs pathogen"/>
 <result pre="they have no competing interests. References References 1.PiersonTCDiamondMSThe emergence of" exact="Zika" post="virus and its new clinical syndromesNature2018560772057358110.1038/s41586-018-0446-y30158602 2.MartinesRBBhatnagarJde Oliveira RamosAMDaviHPIgleziasSDKanamuraCTKeatingMKHaleGSilva-FlanneryLMuehlenbachsAet"/>
 <result pre="its new clinical syndromesNature2018560772057358110.1038/s41586-018-0446-y30158602 2.MartinesRBBhatnagarJde Oliveira RamosAMDaviHPIgleziasSDKanamuraCTKeatingMKHaleGSilva-FlanneryLMuehlenbachsAet al.Pathology of congenital" exact="Zika" post="syndrome in Brazil: a case seriesLancet20163881004789890410.1016/S0140-6736(16)30883-227372395 3.http://www.who.int/emergencies/zika-virus/en/. 4.LiHSaucedo-CuevasLShrestaSGleesonJGThe neurobiology"/>
 <result pre="syndrome in Brazil: a case seriesLancet20163881004789890410.1016/S0140-6736(16)30883-227372395 3.http://www.who.int/emergencies/zika-virus/en/. 4.LiHSaucedo-CuevasLShrestaSGleesonJGThe neurobiology of" exact="Zika" post="virusNeuron201692594995810.1016/j.neuron.2016.11.03127930910 5.YuanLHuangXYLiuZYZhangFZhuXLYuJYJiXXuYPLiGLiCet al.A single mutation in the prM protein"/>
 <result pre="virusNeuron201692594995810.1016/j.neuron.2016.11.03127930910 5.YuanLHuangXYLiuZYZhangFZhuXLYuJYJiXXuYPLiGLiCet al.A single mutation in the prM protein of" exact="Zika" post="virus contributes to fetal microcephalyScience2017358636593393610.1126/science.aam712028971967 6.XiaHLuoHShanCMuruatoAENunesBTDMedeirosDBAZouJXieXGiraldoMIVasconcelosPFCet al.An evolutionary NS1"/>
 <result pre="contributes to fetal microcephalyScience2017358636593393610.1126/science.aam712028971967 6.XiaHLuoHShanCMuruatoAENunesBTDMedeirosDBAZouJXieXGiraldoMIVasconcelosPFCet al.An evolutionary NS1 mutation enhances" exact="Zika" post="virus evasion of host interferon inductionNat Commun20189141410.1038/s41467-017-02816-229379028 7.XieXShanCShiPYRestriction of"/>
 <result pre="Zika virus evasion of host interferon inductionNat Commun20189141410.1038/s41467-017-02816-229379028 7.XieXShanCShiPYRestriction of" exact="Zika" post="virus by host innate immunityCell Host Microbe201619556656710.1016/j.chom.2016.04.01927173920 8.AliotaMTCaineEAWalkerECLarkinKECamachoEOsorioJECharacterization of"/>
 <result pre="virus by host innate immunityCell Host Microbe201619556656710.1016/j.chom.2016.04.01927173920 8.AliotaMTCaineEAWalkerECLarkinKECamachoEOsorioJECharacterization of lethal" exact="Zika" post="virus infection in AG129 micePLoS Negl Trop Dis2016104e000468210.1371/journal.pntd.000468227093158 9.LazearHMGoveroJSmithAMPlattDJFernandezEMinerJJDiamondMSA"/>
 <result pre="in AG129 micePLoS Negl Trop Dis2016104e000468210.1371/journal.pntd.000468227093158 9.LazearHMGoveroJSmithAMPlattDJFernandezEMinerJJDiamondMSA mouse model of" exact="Zika" post="virus pathogenesisCell Host Microbe201619572073010.1016/j.chom.2016.03.01027066744 10.TripathiSBalasubramaniamVRBrownJAMenaIGrantABardinaSVMaringerKSchwarzMCMaestreAMSourisseauMet al.A novel Zika virus"/>
 <result pre="model of Zika virus pathogenesisCell Host Microbe201619572073010.1016/j.chom.2016.03.01027066744 10.TripathiSBalasubramaniamVRBrownJAMenaIGrantABardinaSVMaringerKSchwarzMCMaestreAMSourisseauMet al.A novel" exact="Zika" post="virus mouse model reveals strain specific differences in virus"/>
 <result pre="pathogenesis and host inflammatory immune responsesPLoS Pathog2017133e100625810.1371/journal.ppat.100625828278235 11.SmithDRHollidgeBDayeSZengXBlancettCKuszpitKBocanTKoehlerJWCoyneSMinogueTet al.Neuropathogenesis of" exact="Zika" post="virus in a highly susceptible immunocompetent mouse model after"/>
 <result pre="interferonPLoS Negl Trop Dis2017111e000529610.1371/journal.pntd.000529628068342 12.JaggerBWMinerJJCaoBAroraNSmithAMKovacsAMysorekarIUCoyneCBDiamondMSGestational stage and IFN-lambda signaling regulate" exact="ZIKV" post="infection in uteroCell Host Microbe201722336637610.1016/j.chom.2017.08.01228910635 13.BayerALennemannNJOuyangYBramleyJCMoroskySMarquesETJrCherrySSadovskyYCoyneCBType III interferons produced"/>
 <result pre="III interferons produced by human placental trophoblasts confer protection against" exact="Zika" post="virus infectionCell Host Microbe201619570571210.1016/j.chom.2016.03.00827066743 14.CasazzaRLLazearHMAntiviral immunity backfires: Pathogenic effects"/>
 <result pre="over TRIF adaptor proteins in early innate immune response against" exact="Zika" post="virus in miceJ Gen Virol201899220921810.1099/jgv.0.00099229297844 17.DingQGaskaJMDouamFWeiLKimDBalevMHellerBPlossASpecies-specific disruption of STING-dependent"/>
 <result pre="Virol201899220921810.1099/jgv.0.00099229297844 17.DingQGaskaJMDouamFWeiLKimDBalevMHellerBPlossASpecies-specific disruption of STING-dependent antiviral cellular defenses by the" exact="Zika" post="virus NS2B3 proteaseProc Natl Acad Sci USA201811527E6310E631810.1073/pnas.180340611529915078 18.SunXHuaSChenHROuyangZEinkaufKTseSArdKCiaranelloAYawetzSSaxPet al.Transcriptional"/>
 <result pre="Natl Acad Sci USA201811527E6310E631810.1073/pnas.180340611529915078 18.SunXHuaSChenHROuyangZEinkaufKTseSArdKCiaranelloAYawetzSSaxPet al.Transcriptional changes during naturally acquired" exact="Zika" post="virus infection render dendritic cells highly conducive to viral"/>
 <result pre="MAVSJ Virol201690167219723010.1128/JVI.00221-1627252539 23.YinYXuYSuLZhuXChenMZhuWXiaHHuangXGongSEpidemiologic investigation of a family cluster of imported" exact="ZIKV" post="cases in Guangdong, China: probable human-to-human transmissionEmerg Microbes Infect201659e10027599469"/>
 <result pre="viremia in whole-blood specimensEmerg Infect Dis201723586386510.3201/eid2305.16163128257281 28.MurrayKOGorchakovRCarlsonARBerryRLaiLNatrajanMGarciaMNCorreaAPatelSMAagaardKet al.Prolonged detection of" exact="Zika" post="virus in vaginal secretions and whole bloodEmerg Infect Dis20172319910110.3201/eid2301.16139427748649"/>
</results>
